Industry Symposia

Industry symposia are commercially-supported educational activities held during the ISN World Congress of Nephrology. The symposia are scheduled on Saturday and Sunday from 13:15 – 14:15. One breakfast symposium is scheduled from 07:15 – 08:15 on Sunday. Full details on the symposia programs can be found below and on the Congress app.

Saturday, March 28 – 13:15 - 14:15
Sunday, March 29 – 13:15 - 14:15

Industry Symposia Program

Saturday, March 28

• Title: The burden of Anaemia in CKD: Perspectives from Patient Registries
• Organizer: Astellas
• Room: Hall 4A
• Time: 13:15 – 14:15
• Chair(s): Prof Ziad Massy (France)
• Schedule:

  Time	Title	Speaker
  13:15 - 13:20	Introduction and welcome	Prof Ziad Massy (France)
  13:20 - 13:40	The Complex Picture of Anaemia in CKD: What Challenges Still Remain?	Prof Ziad Massy (France)
  13:40 - 14:00	Anaemia, CKD and Inflammation: Insights from the Swedish Renal Registry	Prof Juan-Jesus Carrero (Sweden)
  14:00 - 14:10	Discussion
  14:10 - 14:15	Summary and close	Prof Ziad Massy, France

• Title: Zydus Nephrology Symposium on Anemia & Transplant
• Organizer: Zydus Nephrosciences, a division of Cadila Healthcare Ltd, India
• Room: Capital Suite 7
• Time: 13:15 – 14:15
• Moderator(s): Dr Sankaran Sundar (India)
• Chair(s): Dr Nizar Attallah (UAE)
  Prof Vivekanand Jha (UK)
  Prof D S Rana (India)
  Prof Vijay Kher (India)
  Prof A K Bhalla (India)
  Prof R K Sharma (India)
• Schedule:

  Time	Title	Speaker(s)
  13:15 - 13:30	Overview of Desidustat – a novel HIF PHI	Dr Deven D Parmar (UAE)
  13:30 - 13:35	Q&A
  13:35 - 13:50	Panel Discussion: HIF-PH Inhibitors – A new ray of hope	Dr Kevin Kumar Kansagra (India) Dr Dinesh Khullar (India) Prof Narayan Prasad (India) Prof Sanjeev Gulati (India) Dr P P Varma (India) Dr Sishir Gang (India) Prof Santosh Varughese (India)
  13:50 - 13:55	Q&A
  13:55 - 14:10	Depleting antibodies in kidney transplantation with ATLG	Prof Ashwani Gupta (India)
  14:10 - 14:15	Q&A

• Title: Coming soon
• Organizer: Terumo BCT
• Room: Conference Hall A
• Time: 07:15 - 08:15

• Title: Genetic Kidney Disease: From innovative diagnosis to new therapeutic targets
• Organizer: Sanofi Genzyme
• Room: Conference Hall B2
• Time: 13:15 – 14:15
• Chair(s): Dr Nizar Attallah (UAE)
• Schedule:

  Time	Title	Speaker
  13:15 - 13:20	Introduction and welcome	Dr Nizar Attallah (UAE)
  13:20 - 13:45	Epidemiology of monogenic kidney diseases and clinical implications	Dr York Pei (Canada)
  13:45 - 14:10	Targeting sphingolipids in rare and common kidney disorders	Dr Tomas Natoli (USA)
  14:10 - 14:15	Q&A	Dr Nizar Attallah (UAE)

Sunday, March 29

• Title: KDIGO Diabetes in CKD Guideline - Individualizing Patient Care: Looking at the Latest Evidence and Beyond
• Organizer: KDIGO, Boehringer Ingelheim
• Room: Hall 4A
• Time: 13:15 – 14:15
• Chair(s): Dr Vlado Perkovic (Australia), Dr David Wheeler (UK)
• Schedule:

  Time	Title	Speaker
  13:15 - 13:20	KDIGO Introduction	Dr David Wheeler (UK)
  13:20 - 13:40	New KDIGO Guideline on the Management of Diabetes in CKD	Dr Peter Rossing (Denmark)
  13:40 - 14:00	Detection, Prevention, and Treatment of CKD in Diabetes	Dr Katherine Tuttle (USA)
  14:00 - 14:15	Patient Perspective: The Human Experience of Living with Diabetes and CKD	Mrs Tami Sadusky (USA)

• Title: Long-term potassium control in cardio-renal patients: overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy
• Organizer: Vifor Pharma
• Room: Conference Hall B2
• Time: 13:15 – 14:15
• Chair(s): Rossignol, Patrick
• Schedule:

  Time	Title	Speaker
  13:15 - 13:20	Welcome and introduction	Rossignol, Patrick
  13:20 - 13:40	RAAS inhibition in patients with cardiorenal involvement: Balancing the benefits and risks	Jardine, Meg
  13:40 - 14:00	New directions in managing the risk of hyperkalaemia	Rossignol, Patrick
  13:40 - 14:00	Discussion
  14:00 - 14:15	Summary and close	Rossignol, Patrick